|
|
Article: Confidence continues.(RXs)(Merck & Company Inc. chief executive officer Richard Clark remains confident about Cordaptive despite its recent disapproval)(Brief article)
- Article from:
- Chain Drug Review
- Article date:
- May 19, 2008
CopyrightCOPYRIGHT 2008 Racher Press, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Merck & Co. chief executive officer Richard Clark remains confident about the future of Cordaptive as a cholesterol treatment despite its recent rejection by federal regulators. The FDA sent the pharmaceutical manufacturer a ...
Related newspaper, magazine, and journal articles:
|
|
Article: Richard Clark elected chairman of PhRMA board.
Pharma Marketletter;
April 14, 2008 ;
373 words
...Richard Clark, president and chief executive of US drug major Merck & Co, has been elected board chairman of the Pharmaceutical Research and Manufacturers of America (PhRMA) at the association's annual meeting. Mr Clark succeeds Amgen CEO Kevin Sharer.
|
|